{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:20:51Z","timestamp":1781360451565,"version":"3.54.1"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,3,15]]},"DOI":"10.2169\/internalmedicine.0168-22","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T22:11:11Z","timestamp":1660947071000},"page":"881-884","source":"Crossref","is-referenced-by-count":5,"title":["Anti-SOX1 Antibody-positive Small-cell Lung Cancer That Triggered Opsoclonus"],"prefix":"10.2169","volume":"62","author":[{"given":"Yuki","family":"Chiko","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Sugisaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Morichika","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Beika","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiki","family":"Ichihara","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Amin OSM, Shwani SS. Opsoclonus. BMJ Case Rep 2017: bcr2017219433, 2017.","DOI":"10.1136\/bcr-2017-219433"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Armangu\u00e9 T, Sabater L, Torres-Vega E, et al. Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol 73: 417-424, 2016.","DOI":"10.1001\/jamaneurol.2015.4607"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sun X, Tan J, Sun H, et al. Anti-SOX1 antibodies in paraneoplastic neurological syndrome. J Clin Neurol 16: 530-546, 2020.","DOI":"10.3988\/jcn.2020.16.4.530"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Candler PM, Dale RC, Griffin S, et al. Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies. J Neurol Neurosurg Psychiatry 77: 507-512, 2006.","DOI":"10.1136\/jnnp.2005.078105"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75: 1135-1140, 2004.","DOI":"10.1136\/jnnp.2003.034447"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wong A. An update on opsoclonus. Curr Opin Neurol 20: 25-31, 2007.","DOI":"10.1097\/WCO.0b013e3280126b51"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bataller L, Graus F, Saiz A; the Spanish Opsoclunus-Myoclonus Study Group. Clinical outcome in adult onset idiopathic paraneoplastic opsoclonus-myoclonus. Brain 124: 437-443, 2001.","DOI":"10.1093\/brain\/124.2.437"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Titulaer MJ, Klooster R, Potman M, et al. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol 27: 4260-4267, 2009.","DOI":"10.1200\/JCO.2008.20.6169"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Vural B, Chen LC, Saip P, et al. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer 103: 2575-2583, 2005.","DOI":"10.1002\/cncr.21088"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. G\u00fcre AO, Stockert E, Scanlan MJ, et al. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Nati Acad Sci U S A 97: 4198-4203, 2000.","DOI":"10.1073\/pnas.97.8.4198"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Honnorat J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet J Rare Dis 2: 22, 2007.","DOI":"10.1186\/1750-1172-2-22"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tanaka K. Paraneoplastic neurological syndromes with reference to anti-neuronal autoantibodies. Rinsho Shinkeigaku (Clin Neurol) 50: 371-378, 2010 (in Japanese, Abstract in English.","DOI":"10.5692\/clinicalneurol.50.371"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Arai H, Utsu Y, Horio J, Furukawa S, Kikkawa Y. Paraneoplastic opsoclonus-myoclonus syndrome with anti-Hu and anti-SOX-1 antibodies after immune-checkpoint inhibitor treatment combined with chemotherapy in a patient with small-cell lung cancer. Intern Med 61: 71-74, 2022.","DOI":"10.2169\/internalmedicine.7167-21"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Horn L, Mansfield AS, Szcz\u0119sna A, et al.; the IMpower 133 Study Group. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med 379: 2220-2229, 2018.","DOI":"10.1056\/NEJMoa1809064"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vogrig A, Mu\u00f1iz-Castrillo S, Desestret V, Joubert B, Honnorat J. Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors. Ther Adv Neurol Disord 13: 1756286420932797, 2020.","DOI":"10.1177\/1756286420932797"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Morimoto T, Orihashi T, Yamasaki K, Tahara M, Kato K, Yatara K. Paraneoplastic sensory polyneuropathy related to anti-PD-L1-including anticancer treatment in a patient with lung cancer. Intern Med 60: 1577-1581, 2021.","DOI":"10.2169\/internalmedicine.5629-20"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/6\/62_0168-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T03:22:40Z","timestamp":1679109760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/6\/62_0168-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0168-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"article-number":"0168-22"}}